From the *Division of Infectious Diseases, Department of Pediatrics, Molecular Microbiology and Immunology, Children’s Hospital Los Angeles, Los Angeles, CA; †Keck School of Medicine, University of Southern California, Los Angeles, CA; ‡Department of Pathology, Children’s Hospital Los Angeles, Los Angeles, CA; and §Center for Global Infectious Disease Research, Seattle Children’s Hospital Research Institute and University of Washington, Seattle, WA.
Accepted for publication June 25, 2014.
S.W. has a patent application pending for a point-of-care diagnostic test to optimize the initial selection of antibiotics for urinary tract infections. The method remains in the developmental stage, and S.W. has received no financial compensation for or benefit from the patented entity. S.W. has also received grant funding from Pfizer to study Antimicrobial Stewardship Program effectiveness at US children’s hospitals. All other authors report no conflicts of interest.
Supported by NIH Grant Number 5 K23 HD072774-02 awarded to P.S.P.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Pia S. Pannaraj, MD, MPH, Children's Hospital Los Angeles, 4650 W. Sunset Blvd., MS#51, Los Angeles, CA 90027. E-mail: [email protected]
